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ABSTRACT 
The liver and pancreas are critical organs maintaining whole body metabolism. Historically, the 
expansion of adult-derived cells from these organs in vitro has proven challenging and this in turn has 
hampered studies of liver and pancreas stem cell biology, as well as being a roadblock to disease 
modelling and cell replacement therapies for pathologies in these organs. Recently, defined culture 
conditions have been described which allow the in vitro culture and manipulation of adult-derived 
liver and pancreatic material. Here we review these systems and assess their physiological relevance, 
as well as their potential utility in biomedicine.   
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1. INTRODUCTION 
The liver and pancreas are solid tissues which arise from the endoderm during vertebrate 
development (Figure 1). Amongst other functions, the liver and pancreas collectively control whole 
organism metabolism, with the pancreas primarily being responsible for the control of glucose 
homeostasis and the liver being responsible for detoxification and the production of urea. Both 
organs also secrete enzymes (pancreas) or solubilising factors (bile from the liver) into the intestine to 
aid in digestion, through the common hepatopancreatic duct, formed by the joining of the common 
bile duct and the pancreatic duct (Figure 1). In addition to similarities in function and morphology in 
adulthood, the liver and the pancreas share a common developmental history, set of early 
morphological patterning events and early transcription factors [1]. Despite the multiple shared 
characteristics of these organs, there are notable differences, key amongst them being that the adult 
pancreas is generally considered to have a much lower regenerative capacity than the liver [2]. Given 
their critical importance in organism physiology, it is not surprising that damage to either tissue can 
result in severely debilitating diseases. Although the liver is well known for its remarkable 
regenerative capacity, repeated damage to the tissue can result in cirrhosis and impairment of liver 
function [3]. In the pancreas, the ablation or loss of function of insulin-secreting β cells leads to 
diabetes mellitus and an inability to control glucose levels. For both organs, inflammation-related 
diseases such as hepatitis (liver) or pancreatitis (pancreas) leads to an increased risk of cancer, with 
the global incidence of both hepatic and pancreatic cancer increasing rapidly [4, 5]. Stem cell biology 
and regeneration in the adult liver and pancreas is therefore a field of interest for both the basic and 
biomedical communities. However, it has been difficult to explore this using in vitro methods, as 
primary cultures of both tissues display little expansion potential in vitro. 
Recently, we and others have turned to 3D cell culture systems in order to investigate the stem cell 
biology of the liver and pancreas. The structures generated in such culture systems have been termed 
“organoids”. Here we adhere to our previous definition of organoid [6] as a 3D structure derived from 
either pluripotent stem cells (PSCs), neonatal tissue stem cells or adult-derived stem/progenitor cells 
(AdSCs), in which cells spontaneously self-organize into structures that resemble the in vivo tissue in 
terms of cellular composition and tissue function. When derived from AdSCs, these share the 
characteristics of bona fide stem cells as described by others [7], namely: 1) self-renewal of a stem cell 
population, usually for prolonged periods, 2) clonal expansion capacity, and 3) multipotency, with the 
stem cell population able to generate at least some of the other cell types seen in the adult tissue in 
vivo. In this review, we will be discussing the origins and characteristics of AdSC-derived liver and 
pancreas organoid cultures as currently described. We will consider each organ separately in term of 
its in vivo biology and the role that 3D in vitro culture has played in uncovering mechanisms of AdSC 
biology. We will also discuss the role that studies of developmental biology have played in 
investigations of AdSC biology and the physiological relevance of such AdSC culture systems. Finally, 
we will summarise the biomedical utility of adult liver and pancreas organoid cultures in the fields of 
regenerative medicine and disease modelling. 
 
2.  LIVER ORGANOID CULTURES 
Stem cells during liver development 
During embryogenesis, the anterior-posterior patterning of naïve endoderm gives rise to an 
epithelium with foregut, midgut and hindgut identities, amongst which the ventral foregut contains 
common precursors for the liver and the pancreas (Figure 1) [1]. This progenitor pool is shared for 
both organs until embryonic day E8.5 in the mouse, when the segregation of presumptive pancreas 
and liver occurs [8]. The lineage choice of these precursors relies on a concentration gradient of 
mesodermal-derived FGF and BMP signals [9-11], whereby higher concentrations specify hepatic fate 
at the expense of a pancreatic one and vice versa [12, 13]. Committed hepatic progenitors -
collectively referred to as hepatoblasts- are bipotential cells that give rise to the two main epithelial 
cell types of the liver: hepatocytes and cholangiocytes [14] and whose journey through development 
is carefully guided by cues from the microenvironment. The budding of the liver as an organ begins at 
E9.5 in the mouse with the migration of hepatoblasts into the adjacent septum transversum 
mesenchyme, a process that also requires the presence of endothelial cells despite the absence of 
blood flow [15] (Figure 1). At later stages, immature ‘mesothelial’ cells surrounding the liver 
parenchyma secrete mitogenic factors such as Hgf, Midkine, and Pleiotrophin [16] that induce 
hepatoblast expansion, whereas mature Thy1+ mesenchymal cells drive hepatoblast maturation by 
direct cell-to-cell contact as shown in a co-culture system [17]. During foetal development, the liver 
serves transiently as a site of hematopoiesis, a period in which it receives cytokines from blood cells 
[18, 19]. 
Hepatoblasts are a population of biomedical interest due to their bipotency, expansion potential and 
ability to contribute to adult liver regeneration when delivered to the site of damage. The collective 
knowledge from hepatogenesis has been harnessed to directly produce hepatocytes [20] or 
cholangiocytes [21] in vitro from pluripotent stem cell cultures (ESCs or iPSCs), by means of stepwise 
addition of defined soluble factors that the microenvironment normally provides in vivo. As an 
alternative to the provision of defined cues, Takebe and colleagues have demonstrated a strategy that 
incorporates embryonic mesenchymal and endothelial cells (MSCs and HUVECs) into a hiPSC-derived 
hepatoblast culture, resulting in the formation of self-organised 3D liver bud-like structures [22]. The 
discussion of such protocols is beyond the scope of this review and will be discussed in detail 
elsewhere in this issue, but the organoids and tissues formed by such methods are useful as a 
comparison to adult-derived organoid cultures. Interestingly, despite using populations that closely 
resemble in vivo hepatoblasts, currently described protocols do not allow the parallel generation of 
both hepatocytes and cholangiocytes in the same structure. As the regeneration of both hepatocyte 
and cholangiocyte compartments is a mainstay of adult liver biology, such bipotency is a key quality in 
assessing the stemness and biomedical utility of organoids generated in vitro. 
Adult liver stem cells and stromal signalling 
While hepatoblasts behave as the functional stem cell of the liver during development, they are 
generally not believed to persist postnatally; the healthy adult liver is a slow cycling tissue where 
epithelial maintenance occurs through the division of diploid cells [23, 24], the self-duplication of 
mature cells [25, 26], and, albeit minimally, through a dedicated AdSC population [14]. Whilst largely 
quiescent during homeostasis, the liver is nonetheless capable of remarkable regeneration when 
challenged (Figure 2). Surgical removal of up to 70% of liver mass - referred to as partial 
hepatectomy- leads to compensatory proliferation and hyperplasia of hepatocytes, restoring tissue 
mass after just one week (reviewed by Michalopolous and DeFrances [27]). Yet, even when 
hepatocyte proliferation is compromised, for example during certain forms of toxic injury, the liver is 
still capable of repairing itself. This property of the liver has given rise to the theory of a facultative 
AdSC population, which has largely polarised the field in terms of its existence [28, 29].  
Pioneering work dating back to the 1950s first described the appearance of small, proliferative, oval-
shaped cells in adult rat livers with early stage carcinomas induced by ethionine or 2- 
acetylaminofluorene [30]. These cells emerge in the vicinity of biliary ducts and contribute to the 
regeneration of both cholangiocytes and hepatocytes (Figure 2) [31]. Morphologically comparable 
adult liver progenitors have been detected in mice using alternative hepatotoxic regimens such as the 
choline-deficient ethionine-supplemented (CDE) diet and administration of the carcinogens 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) or carbon tetrachloride (CCl4) [32-34]. The cellular origin 
of these facultative progenitors has been widely believed to be a subpopulation of the ductal/biliary 
compartment of the liver. Destruction of the biliary tree by 4,4’-methylenedianiline (MDA) in rats 
impairs the proliferation of progenitors in models of oval cell activation [35]. Further to this, the 
existence of bipotent, facultative progenitors of a ductal origin is supported by lineage tracing in vivo 
in damaged livers from cells expressing markers such as Sox9, FoxL1 and Lgr5 [36-39], together with in 
vitro characterisation of these cells. However, a biliary origin for the oval cell has recently been 
challenged by data from the Willenbring and Stanger labs using viral-mediated Cre lineage tracing, 
which convincingly demonstrates that the repair of the damaged liver relies predominantly on the 
hepatocyte compartment [26, 40]. One concept which is able to reconcile these data is that of cellular 
plasticity, whereby the epithelial cell compartments of the liver could be capable of interconversion 
upon damage and thus able to repair one another [41, 42]. Indeed, recent studies have shown that 
the downregulation of Hippo signalling is sufficient to convert hepatocytes into cells expressing 
classical markers of biliary cells (e.g. panCK, Sox9) and oval cells (e.g. MIC1-1C3), although as these 
studies were performed using overexpression of an active form of YAP it is not entirely clear as to how 
frequently such interconversion events may occur under physiological conditions [43]. The concept of 
cellular plasticity has not been applied exclusively to the hepatic epithelium, yet it is possible that the 
evolutionary pressure applied by continuous metabolism of toxic waste has made it a more frequent 
and obvious necessity in this organ (Figure 2). This subject is comprehensively reviewed elsewhere 
[44, 45]. 
Adult liver architecture can be functionally subdivided into hexagon-shaped ‘lobules’ containing a 
central vein in the middle and ‘portal triads’ of arteries, veins and bile ducts at the periphery. 
Extending throughout the lobule there are also liver sinusoidal endothelial cells (LSECs) lining the 
tissue microvasculature, liver resident macrophages (Kupffer cells), lymphoid cells, hepatic stellate 
cells (HSCs) and myofibroblasts (Figure 2). Whilst the origin of the regenerative cell type in the liver 
continues to be contentious, a natural leap has been to focus instead on the signals that control 
regeneration. Similar to the role of stromal-derived cues in the embryo, stromal-derived cues in the 
adult liver could regulate tissue production following damage. Such an idea is an extension of the 
concept of AdSC ‘niches’: specialised microenvironments capable of influencing stem cell fate 
decisions like self-renewal and differentiation [46]. Although this concept was originally developed in 
the field of adult hematopoietic stem cells, it has now been expanded to epithelial tissues, such as the 
small intestine [47]. Following surgical resection of the liver, sinusoidal endothelial cells support tissue 
regeneration by secreting HGF and Wnt2, which increase hepatocyte proliferation [48]. Likewise, 
endothelial cells of the central vein appear to secrete Wnt9b and Rspo3 in addition to Wnt2 during 
homeostasis [23, 49], although it is not known whether these are secreted following damage. IL22 
secretion, which contributes to both hepatectomy-induced regeneration and to the inflammatory 
response during chronic hepatitis B virus infection that leads to progenitor proliferation [50], has 
been recently attributed to innate lymphoid cells of the liver [51]. Of interest, this molecular 
mechanism also seems to be conserved during injury in the small intestine [52]. Takase and 
colleagues showed that Thy1+ mesenchymal cells (including HSCs and myofibroblasts) induce the 
activation and proliferation of murine liver progenitors through Fgf7 secretion, such that forced 
overexpression of this factor alone is sufficient to stimulate progenitor emergence in healthy livers 
[53] (Figure 3). In chronic models of liver damage, Jagged1 expression at the surface of myofibroblasts 
has been shown to favour differentiation of progenitors towards the ductal lineage via Notch 
activation, whereas macrophage-derived Wnt3a has been associated with increased hepatocyte 
commitment [54]. The latter observation must however be reconciled with the reported role of Wnt 
in driving progenitor proliferation [23, 39]. One study found the cytokine profile of HSCs to change 
from pro- to anti-proliferative (HGF to TGFb) at different time-points following CCl4 administration 
[55], thus highlighting the dynamic properties of the niche. It will thus be important to address the 
step-wise involvement of niche-derived signals in driving progenitor dynamics at each stage of 
regeneration in vivo, similar to work performed during embryonic liver development.  
Adult-derived organoids from the liver 
The culture of liver AdSCs has historically proven to be challenging, in spite of the liver’s remarkable 
capacity to proliferate following damage, but studies of liver regeneration in vivo have provided the 
foundations for defined culture conditions that promote the expansion of liver AdSCs in vitro (Figure 
3). We have shown that the Wnt target gene leucine-rich-repeat-containing G-protein-coupled 
receptor 5 (Lgr5) labels actively proliferating cells in the adult mouse liver following toxic damage; 
these cells are capable of differentiating into both hepatocytes and cholangiocytes in vivo, and thus 
meet the criteria of a bi-potential AdSC population [39]. Single Lgr5+ cells can be cultured in 
Matrigel™, an extracellular matrix containing collagen and laminin, and under growth factor-defined 
conditions that include Hgf, Fgf, Egf and, crucially, the Wnt agonist Rspondin1, which is the ligand for 
Lgr5 [56]. Lgr5+ cells expand and self-organise into 3D cystic structures comprised of a single-layer 
epithelium expressing a mixture of progenitor (Lgr5, Trop2), ductal (Krt7, Krt19) and hepatocyte (Ttr, 
Hnf4a) markers. Interestingly, placing healthy biliary ducts under the same culture conditions leads to 
the formation of phenotypically identical organoids [39]. Employing a similar strategy, we further 
established human hepatic organoids from both healthy liver biopsies and single EpCAM+ cells [57]. 
This required modification of the previous media conditions to include inhibition of the TGF-β 
signalling pathway and activation of cAMP signalling (Figure 3). Human adult liver-derived organoids 
express the progenitor marker LGR5 and display a mixture of hepatocyte and ductal markers, thus 
exhibiting phenotypic similarity to murine adult liver-derived organoids. Such similarities suggest a 
conservation of progenitor biology across species in the liver, although specific signalling pathways 
promoting the progenitor state may vary.  
Support for a conserved progenitor population and response comes from the derivation of adult 3D 
liver organoids from other mammalian model systems, for example canines [58]. Whilst dog-derived 
liver organoid cultures recapitulate the features of their mouse and human counterparts, they are 
unique in that their continuous self-renewal relies on Bmp inhibition and Wnt activation achieved by 
supplementing the medium with Noggin and Wnt3a, respectively; signals which are otherwise 
dispensable in the former systems. In conjunction with the human, canine liver organoids do not 
maintain proliferation potential past 3 months without inhibition of Tgf-β signalling (Figure 3). Kuijk 
and colleagues have most recently added to the list of species from which adult liver organoids can be 
generated by deriving rat liver organoid cultures [59]. Rats are a particularly interesting model for 
liver regeneration because of their well-defined progenitor response following injury [47, 60], yet 
somewhat paradoxically, previous efforts to expand these progenitors have been unsuccessful [61]. 
Rat organoids proliferate extensively in vitro and resemble canine ones in their dependence on 
addition of exogenous Wnt and Noggin to maintain the culture, although similar to the mouse they do 
not require Tgf-β inhibition [59].  On the contrary, rat liver organoids cannot maintain proliferation 
past a week when cultured in human organoid medium, suggesting that either Tgf-β inhibition or 
cAMP activation is detrimental for the self-renewal of rat liver progenitors (Figure 3). Whether 
differences in Tgfb-signalling could explain species-specific abilities to activate tissue progenitors in 
vivo is an interesting question which is yet to be addressed. 
A remarkable feature of all adult-derived liver organoid cultures to date, especially considering the 
historical difficulties of primary liver cell culture, is their prolonged capacity for self-renewal (up to 1 
year) at a population doubling rate of 48-60h [39, 57]. Despite this high number of cell divisions, 
organoid cells do not show signs of transformation: studies in human organoids have shown 
remarkable genomic stability at the chromosomal and nucleotide level even at late passages [57]. This 
is an important difference to iPSC-derived organoid cultures, which are often found to have 
accumulated genetic aberrations, most likely caused by the process of reprogramming [62]. All 
organoid cultures studied so far retain the ability to differentiate into functionally mature hepatocytes 
upon withdrawal of proliferative stimuli and the modulation of key signalling pathways that also 
appear to vary slightly according to the species. For instance, addition of dexamethasone in 
combination with inhibition of Notch and TGF-β signalling is sufficient to drive murine organoid 
differentiation, while BMP7 is required as an additional component when directing the differentiation 
of human liver organoids to hepatocytes. The lack of spontaneous hepatocyte differentiation in the 
liver organoids contrasts greatly with that of their intestinal counterparts, where all differentiated cell 
types of the crypt-villus axis are produced in vitro from a single Lgr5+ cell [63]. Although it is tempting 
to attribute this to the innate difference in tissue homeostasis between both organs in vivo (damage-
induced facultative progenitors vs rapidly cycling, bona-fide stem cells ‘pre-programmed’ to replace 
all cell types), organoids from other rapidly cycling epithelial tissues, such as the stomach, also require 
external signalling inputs to drive differentiation into mature cell types [64].  
 
3.  PANCREATIC ORGANOID CULTURES 
Stem cells in pancreatic development and in the adult 
During embryonic development, unlike the liver, the pancreas undergoes simultaneous development 
in both the ventral and dorsal anterior foregut, with the dorsal pancreatic epithelium budding into its 
surrounding mesenchyme and developing separately from the ventral pancreatic bud before 
morphogenetic movements cause both tissues to merge around E13 in the mouse and 7-8 weeks 
post-conception in the human [65]. The multipotent progenitors of the embryonic pancreas will form 
epithelial ducts terminating in acinar cells interspersed with endocrine cells segregated into the islets 
of Langerhans. To form the islets, ductal trunk progenitors will delaminate from the developing ductal 
tree and migrate to form polyclonal endocrine clusters, which will develop into the mature islets [66, 
67]. The adult pancreas is thus composed of three functional compartments arising from separate 
morphogenetic events in development: acinar cells derived from tip cells, ducts remodelled from an 
epithelial plexus and endocrine islets derived from migrating trunk cells (Figure 4). 
The first lineage segregation events occur early in pancreas development when the pancreatic bud 
undergoes separation into tip and trunk cells, with tip cells being identified through expression of 
Cpa1 [68]. As the epithelium develops, tip cells will differentiate into acinar cells whilst trunk cells will 
differentiate into the duct and endocrine lineages. The expression of the basic helix-loop-helix 
transcription factor Neurogenin3 (Neurog3) would appear to be a critical determinant of endocrine 
fate during pancreatic development, as trunk cells expressing Neurog3 will delaminate from the 
forming ductal tree and migrate to form the islets [69, 70]. The islets themselves would appear to 
mature and expand predominantly during postnatal stages, by which time the lineages within the 
pancreas are highly segregated. Indeed, homeostatic maintenance of the adult pancreas would seem 
to be highly compartmentalised, with the majority of reports demonstrating self-duplication of acinar 
and ductal compartments [71-73], with further compartmentalisation within the islets demonstrated 
by self-duplication of β cells [74, 75]. Under homeostatic conditions, interconversion between cell 
types in the healthy adult pancreas would appear to be very low, if not completely absent, and such 
segregated homeostatic turnover is highly comparable to homeostasis in the adult liver (cf Figures 2 
and 4). This compartmentalisation has also been reported to be maintained during damage and 
regeneration, with the specific ablation of β cells resulting in an increased rate of replication in 
remaining β cells [75, 76]. It is tempting to speculate that the strict compartmentalisation observed in 
the pancreas leads to its lower regenerative capacity when compared to the liver. However, 
compartmentalisation of proliferative niches is also well documented in the skin, and yet this organ 
has full regenerative capacity through transient cellular plasticity, which allows for stem cells from 
one compartment to contribute to the repair of other compartments during damage [77]. It is also 
worth placing the regenerative capacity of the pancreas into context, as the organ is capable of full 
functional recovery following certain types of damage, such as partial duct ligation [78], and estimates 
suggest that as much as 90% of β cell mass must be lost before clinical signs of diabetes become 
apparent [79]. It is certainly true though that the pancreas is not capable of the rapid regeneration 
exhibited by the liver to a wide range of physical and toxic insults.  
The comparatively lower regenerative capacity of the pancreas, coupled with the rise in incidence of 
both type1 and type2 diabetes, has led to a search for alternative regenerative mechanisms or cell 
sources which could produce new, functional β cells. In contrast to the liver, there is no 
morphologically distinct cell population which arises during pancreatic regeneration, which has made 
the existence of a facultative, multipotent AdSC population in the pancreas an even more contentious 
issue than for the liver [44]. It would appear that under certain forms of damage, interconversion 
between cell types is possible but highly inefficient. Studies into plasticity in the damaged pancreas 
have been largely informed by events during pancreatic development, particularly the close 
association between the ductal and endocrine lineages that has led many groups to investigate 
whether the mature ductal tree has any capacity for endocrine cell production upon damage in the 
adult. Several groups have reported the reactivation of Neurog3 expression in damaged ducts, 
followed by the formation of novel islets in close association with the ducts [80-83]. The expression of 
Neurog3 in ducts would suggest a dedifferentiation event or the reacquisition of developmental 
potential. However, it is currently unclear as to how mature the newly formed endocrine cells are and 
further, in spite of the acquisition of Neurog3 expression in some ductal cells, which is the cell of 
origin for these new endocrine clusters (Figure 4). Studies in zebrafish have demonstrated that 
centroacinar cells, ductal cells at the acinar termini with elongated cytoplasmic projections, are a cell 
of origin for the production of new endocrine cells [84]. However, it is not clear that mammalian 
centroacinar cells have the same potential to form endocrine cells during damage and the vastly 
increased capacity of the zebrafish pancreas to regenerate would suggest that mechanisms operating 
in the zebrafish may not be present in mammals. Rather than rely on endogenous mechanisms of 
generating new islets, other groups have attempted to direct the transdifferentiation of alternative 
cell types to β cells. It is clear that the overexpression of specific transcription factors can result in the 
interconversion of α cells, duct cells or even acinar cells to β cells in vivo [82, 85, 86]. However, whilst 
informative in terms of the underlying molecular circuitry of tissue compartmentalisation and 
pancreatic plasticity, it is questionable as to whether such approaches will ultimately be of biomedical 
utility.  
Embryonic organoids from the pancreas 
Given the paucity of β cell neogenesis in the adult pancreas, studies of the developing pancreas have 
provided most of our knowledge on the molecular circuitry of the cell types in the adult pancreas. The 
development of the mammalian pancreas can be studied ex vivo by culture with a basic medium at 
the air/liquid interface, a culture system first described in 1954 [87]. The use of this system not only 
revealed the instructive role of the mesenchyme during pancreatic development [88], but further 
suggested that a defined set of signals would be capable of directing a population of multipotent 
progenitors present in the embryonic pancreas. Whilst ex vivo culture allowed the direct investigation 
of pancreatic development by addition of soluble factors to direct differentiation of pancreatic 
explants, the expansion potential of the explants was limited and further manipulation of the explants 
at the interface was difficult. In particular, ex vivo explants could not address the question of whether 
multipotent progenitors required cell-cell interactions for their maintenance and/or differentiation, as 
only entire explants rather than single cells can be cultured using this method. However, by defining 
factors involved in the development of the pancreas, such explant cultures have led to the more 
recent description of culture conditions in which single cells from the E10.5 mouse pancreas can be 
maintained. The embryonic pancreas progenitors grow into 3D organoids which can be expanded for 
up to 2 weeks in culture and retain their potential to differentiate into acinar, ductal or endocrine 
lineages [89]. The embryonic pancreas organoids undergo rapid proliferation and can recapitulate the 
branching structure of the pancreatic epithelium. Because the cells maintain their ability to efficiently 
differentiate into all three lineages, the system is useful for studying signals which bias cell fate 
decisions towards particular lineages. For example, the authors demonstrated that FGF and Notch 
signalling were necessary but not sufficient for the formation of organoids and maintenance of 
progenitor status, mirroring the role of these pathways in vivo during development [90-92]. Also, the 
authors found a role for community effects, as organoids formed more efficiently and maintained 
their progenitor status for longer periods when cultured as groups of cells rather than single cells. 
Such analyses underline the importance of understanding niche signals at the population level in 
order to direct cell fate decisions.  
Adult-derived organoid cultures from the pancreas 
The demonstration of multipotency in organoids formed from embryonic progenitors is an important 
biomedical property, and an a priori requirement for a facultative AdSC capable of regeneration. The 
use of in vitro culture to demonstrate both expansion potential and multipotency is thus an important 
alternative route to identifying cells with the capacity to become a facultative AdSC, even if such 
properties are not present or active in vivo. Using CD133 as a marker, it has been possible to isolate 
cells from the adult mouse pancreas, which demonstrated expansion potential and multipotency in 
vitro in 3D culture [93, 94]. However, organoids grown under these conditions did not display long-
term self-renewal potential and were heterogeneous in their morphology. By contrast, organoids 
formed from adult human CD133+ pancreatic cells were ductal in phenotype and grew as 
homogeneous, hollow spheres composed of a single-layer epithelium [95]. However, endocrine 
differentiation potential was only reported following transfection of the organoids with vectors 
expressing transcription factors known to promote endocrine cell fate. As these factors have been 
reported to induce transdifferentiation of acinar cells to β cells in vivo [85], it is unclear as to whether 
these organoids are multipotent.  
Recently we described the long-term culture of organoids derived from the adult mouse [96] and 
human [97] pancreas using a novel culture system. Following on from our observation that pancreas 
damage by means of pancreatic duct ligation results in upregulation of canonical Wnt signalling [96], 
we defined culture conditions which promoted the growth of organoids by the addition of Rspondin-
1, the Lgr5 ligand, and co-activator of the pathway [56]. Thus, pancreas cells could be cultured and 
give rise to cystic, single-layer organoids, which express ductal markers such as Sox9 and keratin19 as 
well as canonical stem cell markers such as Lgr5 [44, 98] or CD133 [99]. Most strikingly, mouse 
pancreas organoids could be expanded in culture for at least 5 months whilst retaining expansion 
potential [96]. These organoid cultures can also act as bipotent progenitors, being capable of forming 
endocrine cells following grafting into the rat kidney capsule. In searching for the cell-of-origin for the 
organoids, Synaptophysin+ (endocrine) cells were demonstrated to lack organoid-forming potential, 
and Ptf1a+ (acinar) cells generated organoids, which could be maintained for only a few passages in 
vitro. By contrast, Sox9+ ductal cells were shown to form organoids which could be maintained long-
term, in a manner reminiscent of the ductal cell-of-origin for adult liver-derived organoids. Further 
similarity to adult liver-derived organoids was demonstrated by showing that healthy pancreatic ducts 
could give rise to long-term proliferative organoid cultures when placed into the defined culture 
conditions. The similarity of organoid cultures derived from Lgr5+ cells arising in the liver and pancreas 
upon damage has been further highlighted by the report that organoids derived from the adult mouse 
pancreas can transdifferentiate to form hepatocytes in the damaged liver [100]. 
Although Lgr5 expression defines a bipotent population which maintains expansion potential in vitro, 
the ability of organoids to differentiate to an acinar, exocrine fate was not assessed and the Lgr5+ 
population was not traced in vivo to demonstrate incorporation into regenerated endocrine or acinar 
compartments. In addition, the endocrine differentiation capacity of the organoids was very low and 
although detection of C-peptide suggests that β cells formed from organoids are mature, no 
functional tests of insulin release following glucose stimulation or transplantation into diabetic rodent 
models were undertaken. Thus, the ductal organoids generated may accurately mirror a true in vivo 
population in the pancreas, as a variable efficiency of ductal to endocrine conversion has been 
reported specifically following partial duct ligation [80, 101]. In addition, it is unclear as to the 
physiological role that Lgr5 expression plays in the adult pancreas during damage, given that our 
report of a proliferating progenitor conflicts with the use of Rspondin-1 by others to induce endocrine 
differentiation [93]. Identifying the crucial differences between culture systems that lead to differing 
cell responses will be a key step towards fully controlling cell fate decisions in vitro. 
 
4. BIOMEDICAL UTILITY OF ADULT-DERIVED ORGANOID CULTURES 
Discussion above has focussed on the establishment of organoid systems and whether they represent 
a physiologically accurate state. However, as we address below, we believe that organoid technology 
can go beyond this and could contribute to significant biomedical advances by modelling disease 
states (Figure 5). 
Cell therapy  
Several pathologies develop from the failure of the functional cells within the tissue (Figures 2 and 4). 
Considering the many roles of the liver in regulating whole-body homeostasis, it is not surprising that 
loss of function in the hepatocyte compartment leads to hepatic diseases which are often fatal [102]. 
Currently, orthotopic liver transplantation is the only effective treatment for end-stage hepatic 
failure, yet this method is completely reliant on organ donations that are both limited and 
unpredictable [103]. In the pancreas, type 1 diabetes mellitus, results from the loss of β cell function. 
Islet transplantation has proved a successful method for curing diabetes, but the supply of islets is 
limited, even more so than with liver tissue as cadaveric islets must be used. In both cases, the 
recipient is most often required to undertake an immunosuppressive drug regimen for the rest of 
their life [104, 105], an outcome that might not be required if sufficient replacement tissue could be 
generated from the patient themselves. The generation of replacement cells or tissue in vitro is thus a 
cornerstone of regenerative medicine approaches for both organs, to circumvent inadequacies in the 
supply of donor tissue and the requirement for immunosuppression post-transplantation.  
Given their combined expansion and differentiation potential, organoids could serve as a source of 
donor tissue expanded and manipulated ex vivo before re-introduction into the patient (Figure 5). 
This concept has been predominantly explored using liver organoids (also cf. engraftment of intestinal 
organoids into damaged mouse gut epithelium in [106]), with no reports of organoid-generated 
endocrine cells being used to alleviate symptoms in diabetic models to date. As a proof of principle 
for the concept of organoids as a source material for transplantation in the liver, differentiated mouse 
liver organoids were transplanted into Fah-/- mice, a model for tyrosinaemia type I liver disease. 
Organoid-derived Fah+/+ hepatocytes occupied a modest 1% of the liver parenchyma, yet despite this 
managed to increase survival. Compared to ‘gold-standard’ fresh hepatocyte transplantations, 
wherein tissue replacement exceeds 30% and functional rescue is almost complete, organoid graft 
performance is considerably below par. On the other hand, MIC1-1C3+ ‘oval cells’ have also displayed 
only trace engraftment [38], and it is likely that transplantation procedures could be optimised to 
increase effectiveness. Organoid graft success may depend on multiple factors, including the 
differentiation stage of cells introduced and the disease model. Takebe and colleagues have further 
shown that the mesenchymal and vascular components of their embryonic ‘liver bud’ organoids (and 
other iPSC-derived organ-buds, including pancreatic buds) are crucial for establishing communication 
with the host [22, 107]. The lack of stromal support in adult organoids could thus represent a 
disadvantage for therapeutic applications.    
Human hepatic organoids have been tested in their ability to repair livers damaged with 
retrorsine/CCl4, which causes central vein hepatocyte loss [108]. In this study, organoid cells were 
injected in their ductal progenitor state (Krt19+Alb-), yet switched to the hepatocyte lineage 
(Alb+Krt19-) in vivo and contributed to endogenous liver function, implying that host liver signals may 
drive progenitor fate choice [57]. Moreover, the specific type of liver damage (e.g. injuring the biliary 
vs the hepatocyte compartment) may pattern the microenvironment to direct transplanted cells 
towards one fate versus the other, as has been shown by Boulter and colleagues [54].  
Disease modelling and gene therapy 
At present, studies of adult liver function and dysfunction are strongly reliant on animal usage. 
Alternative in vitro models usually consist of primary hepatocyte cultures with limited lifespan 
potential and/or immortalised hepatic lines, such as HepG2 cells, that deviate from normal hepatic 
physiology  [109]. In contrast, adult organoid cultures offer the advantages of genetic stability [57], 
active proliferation and bipotency, thus proving of great biomedical utility for modelling liver 
behaviour in vitro (Figure 5). We have shown that organoids derived from patients diagnosed with a1-
antitrypsin deficiency (A1AT-D) recapitulate the features of the disease upon induction of hepatocyte 
differentiation [57]. The pathology of this disease is attributed to inherited mutations in the SERPINA1 
gene, which lead to misfolding and aggregation of the A1AT protein inside hepatocytes. This work 
would then suggest not only that mutant protein expression is preserved following organoid 
derivation but also that symptoms manifest themselves only under the appropriate cell context (i.e. in 
mature hepatocytes).  
Modelling aspects of cancer biology in vitro would provide platforms for more accurate prognosis, 
prediction of disease progression and drug screening. In this regard, organoid technology provides 
several advantages, not least that the culture conditions allow the rapid expansion of primary 
material for downstream assays (Figure 5). As over 95% of pancreatic cancers arise from the exocrine 
compartment with mutation of KRAS seen in over 90% of these tumours [110], pancreatic ductal 
adenocarcinoma represents a relatively homogeneous pathology in modelling terms. Human adult-
derived pancreatic organoids were seen to recapitulate the features of early- and late-stage cancer 
when derived from patients, including the increased expression of pancreatic adenocarcinoma 
markers (e.g CA19-9), chromosomal abnormalities and neoplastic morphology when xenografted in 
mice [97]. A similar study used the directed differentiation of pluripotent stem cells (PSCs) to the 
exocrine lineage to produce 3D organoid cultures which displayed tumorogenic characteristics 
following transfection with KRASG12D or the dominant-negative mutant of p53, TP53R175H [111]. The 
authors then demonstrated that their PSC-derived organoid culture conditions were also suitable for 
growing primary tumour-derived organoids, using this platform to demonstrate the utility of organoid 
technology for personalised drug screening. Reciprocally, genes believed to have a functional role in 
cancer progression can be assessed in organoid cultures before extending such studies to the more 
expensive and time-consuming animal models. This concept was nicely demonstrated by Westphalen 
and colleagues when identifying the expression of Doublecortin-like kinase 1 (Dclk1) in a 
subpopulation of cells in the pancreas which are activated following damage induced by cerulein 
treatment or partial duct ligation [112]. The authors additionally demonstrated that KrasG12D provides 
resistance to EGF withdrawal in organoid culture only in the presence of functional Dclk1. This in vitro 
observation provided the foundation to uncover the role of Dclk1+ cells as potent tumour-initiating 
cells in the presence of mutant Kras following pancreas damage. 
The fact that 3D organoid cultures are amenable to genome-editing techniques (e.g. CRISPR/Cas9, 
lentiviral transduction), as best shown in pioneering work on gut organoids [113, 114], opens up 
numerous possibilities for disease and repair modelling in vitro (Figure 5). In the liver context, 
Nantasanti and colleagues have restored hepatic organoids from COMMD1-null dogs with the wild-
type COMMD1 gene and managed to restore their ability to excrete copper, a function that is 
otherwise impaired in the livers of these dogs and leads to copper-induced hepatitis [58]. Thus far, 
there are no reports utilising genome-editing in adult-derived pancreas organoid cultures, although 
we note that studies utilising gene correction of CFTR in intestinal organoids [113] would also be 
applicable to disease modelling in pancreas organoids, given the pancreatic phenotype seen in cystic 
fibrosis patients. Such an approach has been utilised in PSC-derived cholangiocytes in combination 
with drug screening to alleviate the effects of mutant CFTR [21]. While adult-derived hepatic 
organoids may prove useful tools for studying monogenic diseases of the epithelial liver 
compartment, liver disorders such as hepatocellular carcinoma and non-alcoholic fatty liver disease, 
pathologies where the cellular microenvironment has been identified as a key component of the 
disease [115, 116], may be more difficult to model accurately with these organoids.  One way of 
circumventing this issue could be to establish co-cultures between adult liver organoids and stromal 
cells, an interaction which automatically occurs in parallel with the establishment of organoid cultures 
in PSC-derived systems [107, 117, 118].  
 
5. CONCLUSION AND FUTURE PERSPECTIVES 
Organoid cultures allow the expansion of adult liver and pancreatic material, which has not been 
possible using more traditional 2D culture methods. The establishment of these systems has allowed 
investigation of the self-renewal and differentiation properties of these tissues in vitro. Similar to the 
use of in vitro hepatoblast and embryonic pancreas explant cultures for investigating the stem cell 
characteristics of these cells [14, 88], we can think of adult-derived organoids as in vitro platforms for 
modelling liver and pancreas regeneration in terms of progenitor activation, proliferation and 
differentiation. A caveat to this usage is that stem cell-like behaviour in vitro can be an artefact of 
removing cells from their native environment and placing them into conditions that promote and 
maintain non-physiological cell states [41]. However, we would point out that firstly, not all cells are 
capable of forming organoids in vitro (e.g. EpCAM- fraction), indicating lineage-specific competence in 
reverting to an uncommitted progenitor state. Secondly, the promotion or maintenance of states 
which are rare in vivo could be of great utility when searching for markers of the AdSC state. This is 
particularly relevant when considering primary pancreatic material, where the role of an in vivo AdSC 
state is particularly controversial [44]. Related to this, the defined nature of the culture conditions 
means that organoid cultures are ideal for studying stem cell-niche interactions in a 3D environment, 
which remains a relatively unexplored area for diseases such as hepatic and pancreatic cancer or type 
2 diabetes. 
In addition to their role in investigating stem cell biology, 3D organoid cultures promise to be of 
considerable biomedical utility. Given their rapid expansion potential, genomic stability and capacity 
to differentiate, adult-derived liver and pancreas organoids could serve as a cell source for assays 
requiring primary cells. In the short term, we foresee advances using the expansion potential of 
organoid culture to provide physiologically relevant assays at a high throughput level, both for normal 
and patient-derived organoids. Such assays could include use in personalised medicine approaches, as 
highlighted for colorectal cancer [119]. In the long term, we expect the advantages of adult-derived 
organoid technology as a genetically stable, non-tumourigenic source material capable of generating 
differentiated cell types [57, 58] to be combined with the advantages of a physiologically relevant 3D 
culture system in defining factors controlling cell fate decisions and result in significant advances in 
the field of cell therapy and regenerative medicine. Overall, we predict that organoids derived from 
the adult liver and pancreas will fulfil a crucial role in biomedicine by providing an accessible but 
physiologically relevant 3D in vitro model system. 
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FIGURE LEGENDS 
Figure 1. A shared hepatopancreatic ductal tree arises during embryogenesis. The liver and ventral 
pancreas arise from the same region of the ventral anterior foregut endoderm during early 
embryogenesis (left image), with both tissues budding into the surrounding mesenchyme later on in 
development (central image). The resulting organs in adulthood share a ductal network of epithelial 
cells (right image), with the secretory cells of each organ directly contacting the ductal network 
(liver/hepatocytes, pink; pancreas/acinar cells, yellow). Lv: liver; Pc (d): dorsal pancreas; Pc (v): ventral 
pancreas; STM: septum transversum mesenchyme. 
 
Figure 2. Tissue architecture of the healthy, regenerating and diseased liver. There is a low rate of 
proliferation in the healthy liver (upper panel) which is increased in all cell types upon damage and 
regeneration (middle panel). In addition to the appearance of an “oval cell” population during 
regeneration, the observed interconversion between cell types (arrows) suggests a high degree of 
tissue plasticity. In the diseased liver, chronically activated mesenchymal cells induce a large degree of 
tissue fibrosis along with impaired regenerative capacity and hepatocyte function. Under these 
conditions, tumours bearing characteristics of hepatocytes (HCC), cholangiocytes (CCA) or a mixture 
of characteristics are more likely to be formed. 
 
Figure 3. Soluble growth factors in vivo and in vitro. Tables comparing the growth factors known to 
regulate liver regeneration in vivo and their cellular source with growth factors used for the culture of 
liver organoids in vitro and additional media components required in vitro are shown. There is a large 
degree of overlap between growth factors enhancing regeneration in vivo and those required for 
long-term expansion of organoids (upper table). Additional soluble factors required for long-term 
growth in vitro are highly dependent upon the species from which organoids are isolated (lower 
table). 
 
Figure 4. Tissue architecture of the healthy and diseased pancreas. During normal homeostasis in the 
healthy pancreas, a low rate of proliferation in each compartment drives maintenance. Tissue 
plasticity is not seen under these conditions. In the disease state, immature endocrine cells can be 
found close to ducts in some models of diabetes and acinar cells undergo acinar-to-ductal metaplasia 
during pancreatic cancer progression. Although this tissue plasticity may suggest a facultative AdSC, 
the existence of such a cell is controversial and it is not shown in this figure. 
 
Figure 5. Biomedical uses of adult organoid culture. (A) Organoids can be generated from healthy liver 
to provide an expandable source of hepatocytes for toxicological testing (lower images) or from 
diseased liver to allow in vitro disease modelling (upper images). Organoids from diseased livers can 
undergo gene correction and repopulate the diseased tissue as a form of cell therapy. (B) Organoids 
can be generated from healthy pancreas to provide an expandable source material for generating β 
cells for cell therapy (lower images) or from diseased pancreas to allow in vitro disease modelling and 
drug screening for personalised medicine approaches. 
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